Tasić IS - Search Results

1

Amlodipine as an antiischemic drug is superior to long acting nitrates.

Koraćević GP, Dakić SS, Veličković-Radovanović RM, Apostolović SR, Krstić NH, Tasić IS, Zdravković MD, Antonijević NM, Damnjanović GN, Kostić TL. Koraćević GP, et al. Among authors: tasic is. Open Med (Wars). 2014 Nov 3;10(1):50-56. doi: 10.1515/med-2015-0011. eCollection 2015. Open Med (Wars). 2014. PMID: 28352677 Free PMC article. Review.

2

[Left atrial size in patients with arterial hypertension].

Milutinović S, Apostolović S, Tasić I. Milutinović S, et al. Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):100-5. doi: 10.2298/sarh0604100m. Srp Arh Celok Lek. 2006. PMID: 16915749 Free article. Serbian.

3

Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.

Djordjevic DB, Tasic IS, Kostic ST, Stamenkovic BN, Lovic MB, Djordjevic ND, Koracevic GP, Lovic DB. Djordjevic DB, et al. Among authors: tasic is. Clin Cardiol. 2020 Sep;43(9):1017-1023. doi: 10.1002/clc.23402. Epub 2020 Jun 3. Clin Cardiol. 2020. PMID: 32492247 Free PMC article.

4

A solution to an almost unrecognizable problem: how can we treat a patient before differentiating between hypertensive urgency and emergency?

Koracevic G, Stojanovic M, Tomasevic M, Simic D, Lovic D, Tasic I. Koracevic G, et al. Expert Opin Pharmacother. 2022 Feb;23(3):285-288. doi: 10.1080/14656566.2021.1999414. Epub 2021 Nov 3. Expert Opin Pharmacother. 2022. PMID: 34727796 No abstract available.

5

QTc dispersion and Cornell duration product can predict 10-year outcomes in hypertensive patients with left ventricular hypertrophy.

Djordjević DB, Tasić IS, Kostić SI, Stamenković BN, Djordjević AD, Lović DB. Djordjević DB, et al. Among authors: tasic is. Clin Cardiol. 2017 Dec;40(12):1236-1241. doi: 10.1002/clc.22815. Epub 2017 Dec 16. Clin Cardiol. 2017. PMID: 29247525 Free PMC article.

6

Predictors of Cardiovascular Events in Hypertensive Patients with High Cardiovascular Risk.

Tasić I, Kostić S, Stojanović NM, Djordjević D, Bogdanović D, Deljanin Ilić M, Lović M, Stoičkov V, Aleksandrić S. Tasić I, et al. Medicina (Kaunas). 2020 Apr 16;56(4):182. doi: 10.3390/medicina56040182. Medicina (Kaunas). 2020. PMID: 32316090 Free PMC article.

7

[Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].

Tasić IS, Mijalković D, Djordjević D, Lović B, Janković D, Miladinović-Tasić N, Lović M. Tasić IS, et al. Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):106-13. doi: 10.2298/sarh0604106t. Srp Arh Celok Lek. 2006. PMID: 16915750 Free article. Clinical Trial. Serbian.

8

Administration and effects of secondary prevention measures in coronary heart disease patients from Serbia according to gender and cardiometabolic risk.

Tasic I, Lazarevic G, Kostic S, Djordjevic D, Simonovic D, Rihter M, Vulic D, Stefanovic V. Tasic I, et al. Acta Cardiol. 2010 Aug;65(4):407-14. doi: 10.2143/AC.65.4.2053899. Acta Cardiol. 2010. PMID: 20821933

9

Predictive value of non-invasive parameters in patients with left ventricular hypertrophy during a five-year follow-up period.

Djordjević D, Tasić I, Stamenković B. Djordjević D, et al. Srp Arh Celok Lek. 2012 Sep-Oct;140(9-10):571-6. Srp Arh Celok Lek. 2012. PMID: 23289271 Free article.

10

Osteoporosis--a risk factor for cardiovascular diseases: a follow-up study.

Tasić I, Popović MR, Stojanović S, Stamenković B, Kostić S, Popović D, Lazarević G, Bogdanović D, Stefanović V. Tasić I, et al. Srp Arh Celok Lek. 2015 Jan-Feb;143(1-2):28-34. doi: 10.2298/sarh1502028t. Srp Arh Celok Lek. 2015. PMID: 25845249 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page